Blood Grouping and Phenotyping Reagents Market continues to demonstrate robust growth, with its valuation reaching USD 1.2 billion in 2024. According to the latest industry analysis, the market is projected to grow at a CAGR of 7.3%, reaching approximately USD 2.1 billion by 2032. This growth is primarily driven by increasing surgical procedures requiring blood transfusions, rising prevalence of blood disorders, and growing awareness about blood safety.
Blood grouping reagents are essential tools used in blood banks and hospitals to determine blood types (ABO and Rh) for safe transfusions. Phenotyping reagents identify specific red blood cell antigens beyond basic blood groups, which is crucial for patients requiring multiple transfusions or with rare blood types. These reagents include monoclonal antibodies, polyclonal antibodies, and antisera used in various testing methods.
Explore In-Depth Market Forecasts: https://www.24chemicalresearch.com/download-sample/291703/blood-grouping-phenotyping-reagents-market
North America dominates the global blood grouping and phenotyping reagents market, accounting for over 38% of total revenue. This leadership position stems from advanced healthcare infrastructure, high adoption of automated systems, and stringent regulatory oversight by the FDA and CDC. The U.S. market benefits from well-established blood banking networks and significant investments in transfusion medicine research.
Europe follows closely, driven by comprehensive EU directives on blood safety and increasing adoption of molecular typing techniques. However, Asia-Pacific is emerging as the fastest-growing region, with countries like China and India investing heavily in modernizing their blood bank infrastructure through national healthcare initiatives.
The market is propelled by several key factors, including rising trauma cases and surgical procedures requiring blood products. With over 118 million blood donations collected globally each year, the demand for accurate blood typing reagents continues to grow. Additionally, technological advancements in automated grouping systems and molecular techniques are creating new opportunities for market expansion.
Significant opportunities exist in developing reagents for rare blood types and expanding testing capabilities in emerging markets. The growing focus on precision medicine and personalized transfusion approaches is driving demand for extended phenotyping panels that can identify over 30 different blood group antigens.
While the market shows strong growth potential, it faces challenges including the high cost of automated systems (often exceeding $100,000 per unit) and specialized reagents. Many healthcare facilities in developing regions still rely on manual methods due to budget constraints. Additionally, stringent regulatory requirements across different regions can delay product launches and increase development costs for manufacturers.
Another significant challenge is the shortage of skilled technicians capable of operating advanced blood typing platforms, particularly for molecular methods that require specialized training.
Market Segmentation by Type
Monoclonal Antibodies
Polyclonal Antibodies
Antisera
Molecular Typing Reagents
Others
Explore In-Depth Market Forecasts: https://www.24chemicalresearch.com/download-sample/291703/blood-grouping-phenotyping-reagents-market
Market Segmentation by Application
Blood Banks
Hospitals
Clinical Laboratories
Research Institutions
Others
Market Segmentation by Technology
Microplate
Gel Cards
Rapid Tests
Automated Systems
Others
Market Segmentation and Key Players
Bio-Rad Laboratories, Inc.
Grifols, S.A.
Ortho Clinical Diagnostics
Thermo Fisher Scientific Inc.
Medion Diagnostics AG
Alba Bioscience
Biotest AG
Immucor, Inc.
Quotient Limited
This report presents a comprehensive analysis of the global and regional markets for Blood Grouping and Phenotyping Reagents, covering the period from 2024 to 2032. It includes detailed insights into the current market status and outlook across various regions and countries, with specific focus on:
Sales, sales volume, and revenue forecasts
Detailed segmentation by type and application
In addition, the report offers in-depth profiles of key industry players, including:
Company profiles
Product specifications
Production capacity and sales
Revenue, pricing, gross margins
Sales performance
It further examines the competitive landscape, highlighting the major vendors and identifying the critical factors expected to challenge market growth.
As part of this research, we surveyed Blood Grouping and Phenotyping Reagents companies and industry experts. The survey covered various aspects, including:
Revenue and demand trends
Product types and recent developments
Strategic plans and market drivers
Industry challenges, obstacles, and potential risks
Get Full Report Here: https://www.24chemicalresearch.com/reports/291703/blood-grouping-phenotyping-reagents-market
About 24chemicalresearch
Founded in 2015, 24chemicalresearch has rapidly established itself as a leader in chemical market intelligence, serving clients including over 30 Fortune 500 companies. We provide data-driven insights through rigorous research methodologies, addressing key industry factors such as government policy, emerging technologies, and competitive landscapes.
Plant-level capacity tracking
Real-time price monitoring
Techno-economic feasibility studies
With a dedicated team of researchers possessing over a decade of experience, we focus on delivering actionable, timely, and high-quality reports to help clients achieve their strategic goals. Our mission is to be the most trusted resource for market insights in the chemical and materials industries.
International: +1(332) 2424 294 | Asia: +91 9169162030
Website: https://www.24chemicalresearch.com/
Follow us on LinkedIn: https://www.linkedin.com/company/24chemicalresearch
Other Related Report:
https://www.linkedin.com/posts/chemical-insights47_pgmea-pma-24chemicalresearch-activity-7370782050980642816-lD1L?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFdjc3YBWo199QxAs1zB5dtI5vdoydUyV_g
https://www.linkedin.com/posts/chemical-insights47_indiaantibioticgrowthpromoters-india-antibiotic-activity-7371493047060303872-Zj0b?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFdjc3YBWo199QxAs1zB5dtI5vdoydUyV_g
https://www.linkedin.com/posts/chemical-insights47_germaniumnanopowder-24chemicalresearch-germaniumnanopowdermarket-activity-7371151536476925953-6s3m?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFdjc3YBWo199QxAs1zB5dtI5vdoydUyV_g
https://www.linkedin.com/posts/chemical-insights47_europeanmetalsputteringtarget-24chemicalresearch-activity-7369674602215653376-Xv7C?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFdjc3YBWo199QxAs1zB5dtI5vdoydUyV_g
https://www.linkedin.com/posts/chemical-insights47_timothygrassgranule-24chemicalresearch-activity-7369337965568888837-Iow6?utm_source=share&utm_medium=member_desktop&rcm=ACoAAFdjc3YBWo199QxAs1zB5dtI5vdoydUyV_g
No comments yet. Be the first. |